Jacobs Levy Equity Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-151
Closed -$144K 1078
2016
Q3
$144K Hold
151
﹤0.01% 940
2016
Q2
$215K Hold
151
﹤0.01% 993
2016
Q1
$185K Sell
151
-33
-18% -$40.4K ﹤0.01% 980
2015
Q4
$238K Sell
184
-4
-2% -$5.17K ﹤0.01% 682
2015
Q3
$272K Buy
188
+39
+26% +$56.4K 0.01% 672
2015
Q2
$329K Buy
149
+8
+6% +$17.7K 0.01% 633
2015
Q1
$419K Buy
141
+36
+34% +$107K 0.01% 599
2014
Q4
$346K Buy
105
+84
+400% +$277K 0.01% 659
2014
Q3
$73K Sell
21
-59
-74% -$205K ﹤0.01% 793
2014
Q2
$308K Buy
80
+20
+33% +$77K 0.01% 708
2014
Q1
$244K Buy
+60
New +$244K ﹤0.01% 785